Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00903448 · ClinicalTrials.gov registry record · Phase 4
Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression
A Phase 4 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00903448 is a Phase 4 study that has completed, run by Procter and Gamble. The registered enrollment target is 40 participants.
The verdict
NCT00903448, a Phase 4 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.
Interventions
- DRUG Prevacid
- DRUG Prilosec OTC (omeprazole-magnesium)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00903448
The ClinicalTrials.gov registry entry for NCT00903448 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prevacid is the first listed.
NCT00903448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00903448 about?
NCT00903448 is a clinical study titled "Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression". The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.
What is the current status of trial NCT00903448?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2009-04. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00903448?
The interventions under investigation include: Prevacid (DRUG), Prilosec OTC (omeprazole-magnesium) (DRUG).
Who is sponsoring clinical trial NCT00903448?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.